International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New corporate member

Arcutis new corporate member

IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a 2022 Bronze Level Corporate Member. Arcutis, based in Westlake Village, CA, is a medical dermatology company founded in 2016 that champions meaningful innovation to solve the most persistent challenges of patients with immune-mediated dermatological diseases and conditions. “We are delighted to welcome Arcutis Biotherapeutics, Inc. to the IPC family, and look forward to partnering with them to improve the care of people with psoriasis worldwide, through education, research and advocacy,” said IPC CEO Christy Langan.

More information about Arcutis can be found at https://www.arcutis.com/.

Categories
Recent Posts
Almirall Press Release Graphic

Happify Health and Almirall Partner Together to Launch Claro

022 SID Congress Report Blog Graphic

Focus on Psoriasis: A Report from the 2022 Society for Investigative Dermatology (SID) Annual Meeting

Lilly Press Release Graphic

Lilly Announces a New, Citrate-Free Formulation of Taltz® (ixekizumab)

Also Read

councilors

New IPC Councilor

Dr. Claus Johansen joins the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.

Read More
councilors

Newest IPC Councilors

Three councilors join the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.